Insmed Investor Relations Material
Latest events
FDA Announcement
Insmed
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Insmed Incorporated
Access all reports
Insmed Incorporated is a biopharmaceutical company focused on developing and commercializing therapies for rare and serious diseases. The company’s research areas include pulmonary conditions, inflammatory diseases, and genetic disorders. It serves patients through approved therapies and a clinical development pipeline. The company is headquartered in Bridgewater, New Jersey, and its shares are listed on the NASDAQ.
Key slides for Insmed Incorporated
43rd Annual J.P. Morgan Healthcare Conference 2025
Insmed Incorporated
Study Update
Insmed Incorporated
Latest articles
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
Ticker symbol
INSM
Country
🇺🇸 United States